Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo

• मुख्य लेखकों: Ming-Xing Zhang (लेखक), Shan-Shan Hong (लेखक), Qing-Qing Cai (लेखक), Meng Zhang (लेखक), Jun Chen (लेखक), Xiao-Yan Zhang (लेखक), Cong-Jian Xu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Ovarian cancer is the leading cause of cancer death among gynecological malignancies. The high mortality rate has not been significantly reduced despite advances in surgery and chemotherapy. Gene therapy shows therapeutic potential, but several key issues must be resolved before clinical application...